Showing results (2401-2410 of 2,674) with videos related to
Sort By:
Pageof 268
Cancer Epidemiology|September 25, 2021
Analgesic use and the risk of renal cell carcinoma - Findings from the Consortium for the Investigation of Renal Malignancies (CONFIRM) studyF J Bruinsma, S Jordan, J K Bassett, et al.Cancer Research|July 14, 1998
Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculatureA K Sills, J I Williams, B M Tyler, et al.Pharmaceutical Research|December 11, 2023
Integrated Exposure-Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population AnalysisEmily Briggs, Mohamed A Kamal, Matthew P Kosloski, et al.BJU International|August 21, 2023
The Dedicated Imaging Post-Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low-risk biochemical recurrence after radical prostatectomyMatthew J Roberts, Ciara Conduit, Ian D Davis, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 6, 2022
Association between early respiratory viral infections and structural lung disease in infants with cystic fibrosisDon B Sanders, Ashley R Deschamp, Joseph E Hatch, et al.Neuroimage. Clinical|February 26, 2020
Interaction of APOE4 alleles and PET tau imaging in former contact sport athletesAnna Vasilevskaya, Foad Taghdiri, Charles Burke, et al.European Radiology|November 7, 2013
Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinomaJoe H Chang, Daryl Lim Joon, Sze Ting Lee, et al.Journal of Lower Genital Tract Disease|May 5, 2005
The vulvodynia guidelineHope K Haefner, Michael E Collins, Gordon D Davis, et al.Clinical Pharmacology and Therapeutics|July 16, 2021
The Posology of Dupilumab in Pediatric Patients With Atopic DermatitisMohamed A Kamal, Pavel Kovalenko, Matthew P Kosloski, et al.Neurology|April 28, 2017
Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD studyHubert H Fernandez, Stewart A Factor, Robert A Hauser, et al.Pageof 268